Toggle Nav
Close
  • Menu
  • Setting

Anti-TNFRSF17/BCMA/CD269 Antibody (Belantamab)

Catalog No.
F1045
Anti-TNFRSF17/BCMA/CD269 Antibody (Belantamab)
Grouped product items
SizePriceStock Qty
100ug
$84.00
Ship with 3-5 days
1mg
$252.00
Ship with 3-5 days
5mg
$655.00
Ship with 3-5 days
50mg
$2,201.00
Ship with 3-5 days
For scientific research use only and should not be used for diagnostic or medical purposes.

Tel: +1-832-696-8203

Email: [email protected]

Worldwide Distributors

Background

Belantamab (GSK2857914) is a humanized IgG1 anti-BCMA (TNFRSF17) monoclonal antibody. Belantamab can be used to synthesize antibody-active molecule conjugates (ADCs), Belantamab mafodotin.

Quality Control

Quality Control & DataSheet

View current batch:
 

M.Wt

146.06 kDa

Shipping

Dry ice

Cas No.

2061894-48-0

Storage

-80°C

Expiration Date

2 years

Form

Liquid

Concentration

See label

Reconstitution

For reconstitution, we recommend adding sterile, distilled water to achieve a final antibody concentration. Gently shake it to solubilize the protein completely. Do not vortex.

Host

CHO

Alternative Names

Bela, GSK-2857914, J6M0

Buffer System

100 mM Pro 20 mM Arg pH 5.0. No preservative!

Target Accession

Q02223

Reactivity

Human, Mouse

Conjugation

Unconjugated

Clonality

Monoclonal

Purification

Protein A

Isotype

IgG1

Application

ELISA, FACS, Kinetics, Functional assay, Animal Model

Biological Activity

U266 cells were stained with Anti-TNFRSF17/BCMA/CD269 Antibody (Belantamab) and negative control protein respectively, washed and then followed by PE and analyzed with FACS

Target

TNFRSF17 / BCMA / CD269

Note

Please avoid freeze-thaw cycles.